Trillin inhibits autophagy and promotes apoptosis in hepatocellular carcinoma cells through activation of the mTOR/STAT3 signaling pathway, suggesting its potential as a therapeutic agent for HCC. The gene discussed is STAT3; the disease is hepatocellular carcinoma.